Blocking the PGAM1-CHK1 interaction destroys senescent cells and slows aging

Accumulation of senescent cells is a central driver of degenerative aging: these cells release inflammatory factors that actively degrade tissue structure and function, accelerating organ decline. Animal studies have demonstrated that selective destruction of senescent cells produces meaningful rejuvenation and reverses the progression of multiple age-related diseases. Researchers have identified that the interaction between PGAM1 (a key metabolic enzyme) and CHK1 (a checkpoint control protein) acts as an amplifier of the glycolysis that energetically fuels these damaged cells and amplifies their inflammatory secretory phenotype known as SASP. Inhibition of this molecular interaction eliminates senescent cells, suppresses their inflammatory profile, and alleviates organ damage and pulmonary fibrosis in animal models. For readers focused on longevity, this represents a potential therapeutic intervention point that could preserve tissue resilience during aging.